ArticleCancers2025

Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study.

Chris W Govaerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.